Rankings
▼
Calendar
BSX FY 2024 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$105B
FY 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$16.7B
+17.6% YoY
Gross Profit
$10.3B
61.3% margin
Operating Income
$2.6B
15.7% margin
Net Income
$1.9B
11.1% margin
EPS (Diluted)
$1.25
Cash Flow
Operating Cash Flow
$3.4B
Free Cash Flow
$2.6B
Stock-Based Comp.
$266M
Balance Sheet
Total Assets
$39.4B
Total Liabilities
$17.4B
Stockholders' Equity
$21.8B
Cash & Equivalents
$414M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16.7B
$14.2B
+17.6%
Gross Profit
$10.3B
$8.8B
+16.3%
Operating Income
$2.6B
$2.2B
+20.8%
Net Income
$1.9B
$1.6B
+16.4%
← Q4 2023
All Quarters
Q1 2024 →